|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 222 Jacobs Street |
Address2 |
|
| City | Cambridge |
State | MA |
Zip Code | 02141 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 31417-12
|
||||||||
|
6. House ID# 309890000
|
||||||||
| TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Christine Fantacone |
Date | 4/22/2024 3:56:35 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 1691, Ensuring Patient Access to Critical Breakthrough Products Act; transitional coverage for emerging technologies (TCET) proposal
Site neutrality payment proposals under Medicare
Medicare Physician Fee Schedule reform
Telehealth reimbursement
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Monica |
Volante |
|
|
|
Elizabeth |
Pika Sharp |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips Electronics, N.V.
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
3rd Party Service regulation
Cybersecurity
Right to Repair of medical devices
Artificial Intelligence and medical devices
Mandatory device shortage reporting proposals
Reauthorization of the Pandemic and All Hazards Preparedness Act (PAHPA)
EPA ethylene oxide (EtO) regulations under FIFRA and NESHAP review - device sterilization
Efforts to improve access to healthcare for underserved communities and activities to enhance maternal healthcare
H.R.3226/S.1573 - PREEMIE Reauthorization Act, all provisions
H.R.3838/S.2415 - Preventing Maternal Deaths Reauthorization Act, all provisions
Sustainability in healthcare throughout the value chain including procurement, product development and design, and the benefits thereof
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Vice President of the U.S.
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Monica |
Volante |
|
|
|
Elizabeth |
Pika Sharp |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips Electronics, N.V.
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY 2024 Veterans Affairs Appropriations, in general with some focus on telehealth provisions
FY 2024 Defense Department Appropriations
2024 National Defense Authorization Act including issues related to RATE and low helium MRIs
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shuman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips Electronics, N.V.
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
U.S. Department of Veteran Affairs' acquisition process
Telehealth for veterans
Tele-critical care for Dept of Defense
Nationwide expansion of tele-critical care program
Digital Pathology
RATE (Rapid Analysis of Threat Exposure)
Recall related to Continuous Positive Air Pressure (CPAP) devices
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shuman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips Electronics, N.V.
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
Telehealth in DOD
Issues related to COVID-19 pandemic response and other infectious diseases
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shuman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips Electronics, N.V.
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CHM
16. Specific lobbying issues
EPA ethylene oxide (EtO) regulations under FIFRA and NESHAP review - device sterilization
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Monica |
Volante |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips Electronics, N.V.
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |